MD Anderson Cancer Center at Cooper - Camden /ID# 145891 — Camden, New Jersey

MD Anderson Cancer Center at Cooper - Camden /ID# 145891 is a clinical research site located in Camden, New Jersey, United States 08103.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

MD Anderson Cancer Center at Cooper - Camden /ID# 145891 has participated in 1 clinical trials.

Therapeutic areas: Glioblastoma, Gliosarcoma.

Sponsors: AbbVie.

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for MD Anderson Cancer Center at Cooper - Camden /ID# 145891?

MD Anderson Cancer Center at Cooper - Camden /ID# 145891 has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has MD Anderson Cancer Center at Cooper - Camden /ID# 145891 conducted?

MD Anderson Cancer Center at Cooper - Camden /ID# 145891 has 1 clinical trials on record. Their work covers Glioblastoma, Gliosarcoma.

Is MD Anderson Cancer Center at Cooper - Camden /ID# 145891 accredited by Crixeo Health?

MD Anderson Cancer Center at Cooper - Camden /ID# 145891 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about MD Anderson Cancer Center at Cooper - Camden /ID# 145891?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.